Unicycive Therapeutics, Inc. revenue for the last year amounted to 675.00 k USD, the most of which — 675.00 k USD — came from its highest performing source at the moment, Novel Therapies, the year earlier bringing 951.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Unicycive Therapeutics, Inc. 675.00 k USD, and the year before that — 951.00 k USD.